BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20659940)

  • 1. The investigation of infants with RhD-negative mothers: can we safely omit the umbilical cord blood direct antiglobulin test?
    James RM; McGuire W; Smith DP
    Arch Dis Child Fetal Neonatal Ed; 2011 Jul; 96(4):F301-4. PubMed ID: 20659940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Has anti-D prophylaxis increased the rate of positive direct antiglobulin test results and can the direct antiglobulin test predict need for phototherapy in Rh/ABO incompatibility?
    Dillon A; Chaudhari T; Crispin P; Shadbolt B; Kent A
    J Paediatr Child Health; 2011 Jan; 47(1-2):40-3. PubMed ID: 20973864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative.
    Chilcott J; Tappenden P; Lloyd Jones M; Wight J; Forman K; Wray J; Beverley C
    BJOG; 2004 Sep; 111(9):903-7. PubMed ID: 15327602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of positive direct antiglobulin tests found on cord blood sampling.
    Dinesh D
    J Paediatr Child Health; 2005; 41(9-10):504-7. PubMed ID: 16150068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The importance of antenatal immunoprophylaxis for prevention of hemolytic disease of the fetus and newborn].
    Starcević M; Mataija M; Sović D; Dodig J; Matijević R; Kukuruzović M
    Acta Med Croatica; 2011 Mar; 65(1):49-54. PubMed ID: 21568074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of the Coombs test in ABO incompatibility].
    Bel Comos J; Ribera Crusafont A; Natal Pujol A; Coroleu Lletget W; Pujol Posch N; Prats Viñas J
    An Esp Pediatr; 1991 Oct; 35(4):248-50. PubMed ID: 1763851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of fetomaternal rhesus-D allo-immunization. Perspectives].
    Cortey A; Brossard Y; Beliard R; Bourel D
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S119-1S122. PubMed ID: 16495837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of preimplantation genetic diagnosis in the management of severe rhesus alloimmunization: first unaffected pregnancy: case report.
    Seeho SK; Burton G; Leigh D; Marshall JT; Persson JW; Morris JM
    Hum Reprod; 2005 Mar; 20(3):697-701. PubMed ID: 15661826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of fetomaternal rhesus-D allo-immunization. Practical aspects].
    Cortey A; Brossard Y
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S123-1S130. PubMed ID: 16495838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A curious case of anti-D antibody titer.
    Hensley JG; Coughlin KP; Klein LL
    J Midwifery Womens Health; 2009; 54(6):497-502. PubMed ID: 19879523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RHD genotyping from maternal plasma: guidelines and technical challenges.
    Avent ND
    Methods Mol Biol; 2008; 444():185-201. PubMed ID: 18425481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of positive direct anti-globulin test for cord blood--in administration of anti-d immunoglobulin for postpartum immunoprophylaxis.
    Nakamura Y; Sada I; Tanaka S; Nomura Y; Shinagawa S
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Apr; 36(4):623-5. PubMed ID: 6425437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal RhD genotyping: a more efficient use of anti-D immunoglobulin.
    Daniels G; Finning K; Martin P; Summers J
    Transfus Clin Biol; 2007 Dec; 14(6):568-71. PubMed ID: 18436463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fetal and neonatal outcomes of Rhesus D antibody affected pregnancies in Northern Ireland.
    Craig S; Morris K; Tubman T; McClure B
    Ir Med J; 2000; 93(1):17-8. PubMed ID: 10740367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal anti-D prophylaxis during pregnancy does not cause neonatal haemolysis.
    Maayan-Metzger A; Schwartz T; Sulkes J; Merlob P
    Arch Dis Child Fetal Neonatal Ed; 2001 Jan; 84(1):F60-2. PubMed ID: 11124929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing RhD haemolytic disease of the newborn. Services should be centralised for pregnancies affected by RhD haemolytic disease.
    Craig JS; McClure BG; Tubman TR
    BMJ; 1998 May; 316(7144):1611. PubMed ID: 9616034
    [No Abstract]   [Full Text] [Related]  

  • 17. Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies.
    Tiblad E; Westgren M; Pasupathy D; Karlsson A; Wikman AT
    Acta Obstet Gynecol Scand; 2013 Sep; 92(9):1079-85. PubMed ID: 23750781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the enzyme test for the detection of clinically significant red blood cell antibodies during pregnancy.
    Hundrić-Haspl Z; Juraković-Loncar N; Grgicević D
    Acta Med Croatica; 1999; 53(3):125-8. PubMed ID: 10705633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic basis and immunoprophylaxis of RhD induced hemolytic disease of the newborn (HDN).
    Payam Khaja Pasha R; Shokri F
    Iran J Immunol; 2008 Dec; 5(4):189-200. PubMed ID: 19098362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RhD haemolytic disease of the fetus and the newborn.
    Urbaniak SJ; Greiss MA
    Blood Rev; 2000 Mar; 14(1):44-61. PubMed ID: 10805260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.